z-logo
open-access-imgOpen Access
Bilirubin
Author(s) -
Robert Öllinger,
Martin Bilban,
Anna Erat,
Alberto Froio,
James McDaid,
Shivraj Tyagi,
Eva Csizmadia,
Aurélio V. Graça-Souza,
A Liloia,
Miguel P. Soares,
Leo E. Otterbein,
Anny Usheva,
Kenichiro Yamashita,
Fritz H. Bach
Publication year - 2005
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.104.528802
Subject(s) - medicine , intensive care medicine
Bilirubin, a natural product of heme catabolism by heme oxygenases, was considered a toxic waste product until 1987, when its antioxidant potential was recognized. On the basis of observations that oxidative stress is a potent trigger in vascular proliferative responses, that heme oxygenase-1 is antiatherogenic, and that several studies now show that individuals with high-normal or supranormal levels of plasma bilirubin have a lesser incidence of atherosclerosis-related diseases, we hypothesized that bilirubin would have salutary effects on preventing intimal hyperplasia after balloon injury.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom